ARK Innovation ETF (ARKK) and Motley Fool Next Index ETF (TMFX) appeal to investors seeking U.S. equity growth exposure but pursue markedly different strategies. ARKK employs active management centered on disruptive innovation themes, while TMFX tracks a passive index of mid- and small-cap companies favored by Motley Fool research. They do not compete directly as substitutes; instead, they offer complementary approaches to growth investing—one driven by thematic conviction and the other by systematic, analyst-informed selection. This comparison helps investors evaluate structural trade-offs in cost, diversification, and thematic positioning within the current market environment.
ARK Innovation ETF (ARKK) is an actively managed exchange-traded fund that seeks long-term capital growth by investing primarily in domestic and foreign equity securities tied to the theme of disruptive innovation. The fund typically holds 30 to 50 positions, with significant allocations to technology and healthcare companies. Top holdings often include names such as Tesla Inc. (TSLA), CRISPR Therapeutics AG (CRSP), and Advanced Micro Devices Inc. (AMD). Sector allocations emphasize technology services and health technology. The expense ratio stands at 0.75%. As a non-diversified, actively managed vehicle, ARKK features higher portfolio turnover driven by the manager’s conviction-based rebalancing rather than a fixed index methodology.
Motley Fool Next Index ETF (TMFX) is a passively managed exchange-traded fund that tracks the Motley Fool Next Index, a market-cap-weighted index of mid- and small-cap U.S. companies recommended by Motley Fool analysts and newsletters, excluding the 100 largest securities. The ETF holds approximately 194 positions, providing broad diversification within the extended U.S. equity market. Top holdings typically feature companies such as Workday Inc. (WDAY), Veeva Systems Inc. (VEEV), and MongoDB Inc. (MDB). Sector exposure spans technology, healthcare, and industrials. The expense ratio is 0.50%. The fund follows a rules-based, market-cap-weighted methodology with periodic index reconstitution, resulting in lower turnover than actively managed peers.
Both ETFs operate within the U.S. growth equity landscape, particularly mid- and small-cap segments influenced by technological advancement, healthcare innovation, and economic expansion. Key macro drivers include interest-rate expectations, corporate earnings cycles in technology and healthcare, and capital flows into innovation-driven companies. Regulatory developments around artificial intelligence, biotechnology approvals, and data privacy continue to shape sector dynamics. Risks include heightened volatility in smaller-capitalization names, potential shifts in investor risk appetite, and competitive pressures within high-growth industries. The environment favors strategies that balance thematic exposure with cost-efficient diversification.
In recent market cycles, ARKK has exhibited greater sensitivity to thematic rotations and earnings surprises among its concentrated holdings, leading to higher volatility relative to broader benchmarks. TMFX, with its wider holdings base and lower expense ratio, has shown more measured participation in mid- and small-cap rallies driven by systematic selection. Relative positioning highlights ARKK’s potential for outsized gains during innovation-led advances and TMFX’s emphasis on diversified exposure to analyst-recommended growth companies. Differences in rebalancing and cost structures influence how each fund responds to sector momentum and macroeconomic shifts over multi-month periods.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Investors seeking data-driven insights into ETFs like ARKK and TMFX may find the tool useful for refining their research process.
Based on observable structural factors, Tickeron’s AI would likely assign a modest preference to Motley Fool Next Index ETF (TMFX) in the current environment. Its lower expense ratio, broader diversification across nearly 200 holdings, and passive rules-based methodology provide greater cost efficiency and reduced single-name risk compared with the more concentrated, higher-cost active approach of ARK Innovation ETF (ARKK). While ARKK offers differentiated thematic exposure, TMFX’s profile aligns more closely with consistent sector momentum and risk-adjusted positioning across recent market cycles.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| ARKK | TMFX | ARKK / TMFX | |
| Gain YTD | 12.077 | 15.354 | 79% |
| Net Assets | 6.64B | 35.4M | 18,746% |
| Total Expense Ratio | 0.75 | 0.50 | 150% |
| Turnover | 43.00 | 27.00 | 159% |
| Yield | 0.00 | 0.05 | - |
| Fund Existence | 12 years | 5 years | - |
| ARKK | TMFX | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 90% | 3 days ago 79% |
| Stochastic ODDS (%) | 3 days ago 90% | 3 days ago 79% |
| Momentum ODDS (%) | 3 days ago 90% | 3 days ago 84% |
| MACD ODDS (%) | 3 days ago 87% | 3 days ago 80% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 84% |
| TrendMonth ODDS (%) | 3 days ago 88% | 3 days ago 86% |
| Advances ODDS (%) | 11 days ago 89% | 20 days ago 84% |
| Declines ODDS (%) | 18 days ago 89% | 6 days ago 79% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 82% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 86% |
A.I.dvisor indicates that over the last year, ARKK has been closely correlated with RXRX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARKK jumps, then RXRX could also see price increases.
| Ticker / NAME | Correlation To ARKK | 1D Price Change % | ||
|---|---|---|---|---|
| ARKK | 100% | +3.53% | ||
| RXRX - ARKK | 73% Closely correlated | +4.79% | ||
| ACHR - ARKK | 69% Closely correlated | +3.45% | ||
| SE - ARKK | 61% Loosely correlated | +0.25% | ||
| FIRY - ARKK | 60% Loosely correlated | -4.59% | ||
| DDD - ARKK | 56% Loosely correlated | +0.95% | ||
More | ||||
A.I.dvisor indicates that over the last year, TMFX has been closely correlated with UPST. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMFX jumps, then UPST could also see price increases.
| Ticker / NAME | Correlation To TMFX | 1D Price Change % | ||
|---|---|---|---|---|
| TMFX | 100% | +1.17% | ||
| UPST - TMFX | 67% Closely correlated | +4.99% | ||
| SOFI - TMFX | 60% Loosely correlated | +5.52% | ||
| ACHR - TMFX | 54% Loosely correlated | +3.45% | ||
| ALRM - TMFX | 54% Loosely correlated | +0.79% | ||
| WSM - TMFX | 54% Loosely correlated | +0.80% | ||
More | ||||